Compagnie Lombard Odier SCmA’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,920
| Closed | -$506K | – | 673 |
|
|
2022
Q2 | $506K | Sell |
7,920
-5,280
| -40% | -$337K | 0.01% | 200 |
|
|
2022
Q1 | $855K | Hold |
13,200
| – | – | 0.02% | 165 |
|
|
2021
Q4 | $878K | Buy |
+13,200
| New | +$878K | 0.02% | 190 |
|
|
2016
Q3 | – | Sell |
-450
| Closed | -$22K | – | 906 |
|
|
2016
Q2 | $22K | Hold |
450
| – | – | ﹤0.01% | 771 |
|
|
2016
Q1 | $21K | Sell |
450
-9,804
| -96% | -$458K | ﹤0.01% | 820 |
|
|
2015
Q4 | $552K | Hold |
10,254
| – | – | 0.02% | 299 |
|
|
2015
Q3 | $506K | Buy |
10,254
+810
| +9% | +$40K | 0.02% | 272 |
|
|
2015
Q2 | $550K | Hold |
9,444
| – | – | 0.02% | 291 |
|
|
2015
Q1 | $543K | Sell |
9,444
-9,000
| -49% | -$517K | 0.02% | 302 |
|
|
2014
Q4 | $930K | Buy |
+18,444
| New | +$930K | 0.04% | 204 |
|